$IART
Integra Lifesciences Holdings Corp

2016 Q1 Form 10-Q Financial Statement

#000091752016000084 Filed on April 27, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $236.8M $202.5M
YoY Change 16.9% -5.82%
Cost Of Revenue $84.77M $75.22M
YoY Change 12.7% -8.69%
Gross Profit $152.0M $127.3M
YoY Change 19.39% 13.11%
Gross Profit Margin 64.2% 62.86%
Selling, General & Admin $112.0M $93.27M
YoY Change 20.06% -13.91%
% of Gross Profit 73.67% 73.26%
Research & Development $14.45M $11.08M
YoY Change 30.44% -11.84%
% of Gross Profit 9.51% 8.7%
Depreciation & Amortization $18.25M $11.80M
YoY Change 54.69% -15.48%
% of Gross Profit 12.01% 9.27%
Operating Expenses $126.4M $104.3M
YoY Change 21.16% -13.7%
Operating Profit $22.10M $21.24M
YoY Change 4.05% 143.08%
Interest Expense $6.373M $5.472M
YoY Change 16.47% 6.42%
% of Operating Profit 28.84% 25.76%
Other Income/Expense, Net -$738.0K $2.017M
YoY Change -136.59% 536.28%
Pretax Income $15.00M $17.79M
YoY Change -15.71% 347.55%
Income Tax $1.576M $6.058M
% Of Pretax Income 10.51% 34.05%
Net Earnings $13.42M $8.384M
YoY Change 60.05% 280.05%
Net Earnings / Revenue 5.67% 4.14%
Basic Earnings Per Share $0.18 $0.13
Diluted Earnings Per Share $0.18 $0.13
COMMON SHARES
Basic Shares Outstanding 73.93M shares 32.74M shares
Diluted Shares Outstanding 76.47M shares 33.34M shares

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $77.10M $79.90M
YoY Change -3.5% -38.06%
Cash & Equivalents $77.09M $79.87M
Short-Term Investments
Other Short-Term Assets $43.90M $82.30M
YoY Change -46.66% -0.84%
Inventory $222.0M $233.0M
Prepaid Expenses
Receivables $151.6M $126.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $494.6M $522.0M
YoY Change -5.25% -3.3%
LONG-TERM ASSETS
Property, Plant & Equipment $210.3M $210.1M
YoY Change 0.1% 2.16%
Goodwill $516.1M $354.2M
YoY Change 45.71% -3.66%
Intangibles $594.9M $447.4M
YoY Change 32.95% 4.19%
Long-Term Investments
YoY Change
Other Assets $7.280M $11.44M
YoY Change -36.34% 47.18%
Total Long-Term Assets $1.336B $1.029B
YoY Change 29.82% 1.25%
TOTAL ASSETS
Total Short-Term Assets $494.6M $522.0M
Total Long-Term Assets $1.336B $1.029B
Total Assets $1.830B $1.551B
YoY Change 18.02% -0.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $54.00M $42.60M
YoY Change 26.76% -8.19%
Accrued Expenses $44.84M $41.04M
YoY Change 9.26% 8.87%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $17.80M $5.600M
YoY Change 217.86%
Total Short-Term Liabilities $156.6M $126.8M
YoY Change 23.52% 8.54%
LONG-TERM LIABILITIES
Long-Term Debt $712.2M $611.4M
YoY Change 16.49% -2.8%
Other Long-Term Liabilities $28.61M $32.05M
YoY Change -10.73% -11.67%
Total Long-Term Liabilities $28.61M $32.05M
YoY Change -10.73% -11.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $156.6M $126.8M
Total Long-Term Liabilities $28.61M $32.05M
Total Liabilities $1.054B $862.7M
YoY Change 22.16% -1.6%
SHAREHOLDERS EQUITY
Retained Earnings $157.6M $323.3M
YoY Change -51.27% 14.19%
Common Stock $1.023B $779.5M
YoY Change 31.19% 2.4%
Preferred Stock
YoY Change
Treasury Stock (at cost) $367.1M $367.1M
YoY Change 0.0% 0.0%
Treasury Stock Shares 8.915M shares 8.903M shares
Shareholders Equity $776.4M $688.1M
YoY Change
Total Liabilities & Shareholders Equity $1.830B $1.551B
YoY Change 18.02% -0.33%

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income $13.42M $8.384M
YoY Change 60.05% 280.05%
Depreciation, Depletion And Amortization $18.25M $11.80M
YoY Change 54.69% -15.48%
Cash From Operating Activities $25.03M $31.62M
YoY Change -20.84% 180.96%
INVESTING ACTIVITIES
Capital Expenditures $10.90M $5.330M
YoY Change 104.41% -52.98%
Acquisitions $0.00 $0.00
YoY Change -100.0%
Other Investing Activities $4.200M $3.300M
YoY Change 27.27% -101.4%
Cash From Investing Activities -$6.730M -$5.632M
YoY Change 19.5% -97.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $9.952M -$13.83M
YoY Change -171.98% -105.69%
NET CHANGE
Cash From Operating Activities $25.03M $31.62M
Cash From Investing Activities -$6.730M -$5.632M
Cash From Financing Activities $9.952M -$13.83M
Net Change In Cash $28.25M $12.16M
YoY Change 132.32% 50.27%
FREE CASH FLOW
Cash From Operating Activities $25.03M $31.62M
Capital Expenditures $10.90M $5.330M
Free Cash Flow $14.14M $26.29M
YoY Change -46.23% -32555.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000917520
CY2016Q1 dei Amendment Flag
AmendmentFlag
false
CY2016Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016Q1 dei Document Period End Date
DocumentPeriodEndDate
2016-03-31
CY2016Q1 dei Document Type
DocumentType
10-Q
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37218896 shares
CY2016Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2016Q1 dei Entity Registrant Name
EntityRegistrantName
INTEGRA LIFESCIENCES HOLDINGS CORP
CY2016Q1 dei Trading Symbol
TradingSymbol
iart
CY2014Q4 iart Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedge Effect Before Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgeEffectBeforeTax
-898000 USD
CY2015Q1 iart Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedge Effect Before Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgeEffectBeforeTax
-527000 USD
CY2015Q4 iart Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill
CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
770446000 USD
CY2016Q1 iart Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill
CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
773193000 USD
CY2015Q4 iart Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill
DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
603740000 USD
CY2016Q1 iart Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill
DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
594856000 USD
CY2016Q1 iart Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans
3 plan
CY2015Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
34772000 USD
CY2016Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
53993000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
132241000 USD
CY2016Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
151607000 USD
CY2015Q1 us-gaap Accretion Expense
AccretionExpense
1859000 USD
CY2016Q1 us-gaap Accretion Expense
AccretionExpense
2064000 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39160000 USD
CY2016Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44839000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-47902000 USD
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-36665000 USD
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1020128000 USD
CY2016Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1022150000 USD
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5572000 USD
CY2016Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6015000 USD
CY2015Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
530000 USD
CY2016Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
616000 USD
CY2015Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1729000 USD
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3471000 USD
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000 shares
CY2015Q4 us-gaap Assets
Assets
1774224000 USD
CY2016Q1 us-gaap Assets
Assets
1830262000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
438495000 USD
CY2016Q1 us-gaap Assets Current
AssetsCurrent
494565000 USD
CY2015Q1 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.41
CY2015Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
13308000 USD
CY2015Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
225471000 USD
CY2015Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
125000 USD
CY2016Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
131000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71994000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
79871000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48132000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
77086000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7877000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
28954000 USD
CY2015Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-3571000 USD
CY2016Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0 USD
CY2015Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
6728000 USD
CY2016Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45857000 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45992000 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
459000 USD
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
460000 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15744000 USD
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22885000 USD
CY2015Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
218240000 USD
CY2016Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
220626000 USD
CY2015Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
75221000 USD
CY2016Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
84773000 USD
CY2015Q1 us-gaap Costs And Expenses
CostsAndExpenses
181294000 USD
CY2016Q1 us-gaap Costs And Expenses
CostsAndExpenses
214651000 USD
CY2015Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1341000 USD
CY2016Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
942000 USD
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5666000 USD
CY2016Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7222000 USD
CY2015Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
6932000 USD
CY2016Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
7128000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
154891000 USD
CY2016Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
156449000 USD
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11800000 USD
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18253000 USD
CY2016Q1 us-gaap Derivative Description Of Terms
DerivativeDescriptionOfTerms
August 10, 2015
CY2015Q1 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-389000 USD
CY2015Q1 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-18000 USD
CY2015Q1 us-gaap Derivative Net Hedge Ineffectiveness Gain Loss
DerivativeNetHedgeIneffectivenessGainLoss
0 USD
CY2016Q1 us-gaap Derivative Number Of Instruments Held
DerivativeNumberOfInstrumentsHeld
0 instrument
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-4284000 USD
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
702000 USD
CY2015Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.341
CY2016Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.224
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
45154000 USD
CY2016Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
32763000 USD
CY2015Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1121000 USD
CY2016Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1808000 USD
CY2015Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1121000 USD
CY2016Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1808000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
166706000 USD
CY2016Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
178337000 USD
CY2016Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
41500000 USD
CY2016Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
40200000 USD
CY2016Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
40400000 USD
CY2016Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
40400000 USD
CY2016Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
40900000 USD
CY2015Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
19000 USD
CY2016Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-61000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
512389000 USD
CY2016Q1 us-gaap Goodwill
Goodwill
516103000 USD
CY2016Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
3714000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
11732000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
11648000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17790000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
15014000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
11732000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
11648000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.36
CY2016Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.32
CY2015Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.35
CY2016Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.31
CY2015Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-3348000 USD
CY2016Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
CY2015Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.10
CY2016Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2015Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.10
CY2016Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2015Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
30000 shares
CY2016Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
653000 shares
CY2015Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
576000 shares
CY2016Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
521000 shares
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
603740000 USD
CY2016Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
594856000 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
5472000 USD
CY2016Q1 us-gaap Interest Expense
InterestExpense
6373000 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6058000 USD
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3366000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4347000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8006000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-554000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18440000 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-769000 USD
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1527000 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4864000 USD
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8104000 USD
CY2015Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1521000 USD
CY2016Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-386000 USD
CY2015Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
568000 USD
CY2016Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
601000 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4829000 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2016000 USD
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
125869000 USD
CY2016Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
130514000 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
211429000 USD
CY2016Q1 us-gaap Inventory Net
InventoryNet
221978000 USD
CY2015Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
37598000 USD
CY2016Q1 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
40301000 USD
CY2015Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
47962000 USD
CY2016Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
51163000 USD
CY2015Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
5000 USD
CY2016Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
6000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
1022781000 USD
CY2016Q1 us-gaap Liabilities
Liabilities
1053875000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1774224000 USD
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1830262000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
139127000 USD
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
156630000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13826000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15811000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5632000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6730000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2061000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-6730000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
31619000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19171000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
24891000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
19171000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
8384000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
11648000 USD
CY2015Q3 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
2 acquisition
CY2016Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
21240000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
22119000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7487000 USD
CY2016Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7280000 USD
CY2015Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
54000 USD
CY2016Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-7000 USD
CY2015Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-24393000 USD
CY2016Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
11244000 USD
CY2015Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
211000 USD
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
0 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
28648000 USD
CY2016Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
28607000 USD
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2017000 USD
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-738000 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5330000 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10895000 USD
CY2015Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2016Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
42620000 USD
CY2016Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
43894000 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 USD
CY2016Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
15000000 USD
CY2015Q1 us-gaap Proceeds From Previous Acquisition
ProceedsFromPreviousAcquisition
1831000 USD
CY2016Q1 us-gaap Proceeds From Previous Acquisition
ProceedsFromPreviousAcquisition
0 USD
CY2015Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1438000 USD
CY2016Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2015Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 USD
CY2016Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
4165000 USD
CY2015Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
231000 USD
CY2016Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1038000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
205181000 USD
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
210330000 USD
CY2015Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
178000 USD
CY2016Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
160000 USD
CY2015Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
15000000 USD
CY2016Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1875000 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11079000 USD
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14451000 USD
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4073000 USD
CY2016Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
145879000 USD
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
157563000 USD
CY2015Q1 us-gaap Revenues
Revenues
202534000 USD
CY2016Q1 us-gaap Revenues
Revenues
236770000 USD
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
202534000 USD
CY2016Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
236770000 USD
CY2015Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
14375000 USD
CY2016Q1 us-gaap Secured Debt Current
SecuredDebtCurrent
17813000 USD
CY2015Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
481875000 USD
CY2016Q1 us-gaap Secured Long Term Debt
SecuredLongTermDebt
491563000 USD
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
93265000 USD
CY2016Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
111956000 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2288000 USD
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3246000 USD
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P3Y
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
111662 shares
CY2016Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
75000000 USD
CY2015Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2016Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
751443000 USD
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
776387000 USD
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
8915000 shares
CY2016Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
8915000 shares
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
367121000 USD
CY2016Q1 us-gaap Treasury Stock Value
TreasuryStockValue
367121000 USD
CY2016Q1 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
300000 USD
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33342000 shares
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38141000 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32736000 shares
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36967000 shares

Files In Submission

Name View Source Status
0000917520-16-000084-index-headers.html Edgar Link pending
0000917520-16-000084-index.html Edgar Link pending
0000917520-16-000084.txt Edgar Link pending
0000917520-16-000084-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
iart-20160331.xml Edgar Link completed
iart-20160331.xsd Edgar Link pending
iart-2016033110xq.htm Edgar Link pending
iart-20160331xexx311.htm Edgar Link pending
iart-20160331xexx312.htm Edgar Link pending
iart-20160331xexx321.htm Edgar Link pending
iart-20160331xexx322.htm Edgar Link pending
iart-20160331_cal.xml Edgar Link unprocessable
iart-20160331_def.xml Edgar Link unprocessable
iart-20160331_lab.xml Edgar Link unprocessable
iart-20160331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending